US 11130795
CD154 peptides and methods of inhibiting CD40 interactions with CD154
granted A61KA61K38/08A61K38/10
Quick answer
US patent 11130795 (CD154 peptides and methods of inhibiting CD40 interactions with CD154) held by The Regents of the University of Colorado expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K38/1774